Greg Levine

Greg Levine is the counsel of choice for life sciences companies confronting their most consequential FDA challenges. Drawing on decades of experience, he steers pharmaceutical, biotechnology, and medical device manufacturers through every stage of the product lifecycle—designing regulatory strategies, securing marketing authorization, shaping labeling and promotional campaigns, responsibly addressing product safety issues, and handling FDA and related government agency inspections, investigations, and enforcement actions. Greg combines technical fluency with practical business judgment to offer advice and solutions that protect products, preserve reputations, and accelerate time to market.

The legal community recognizes Greg’s mastery of FDA law. Chambers USA ranks him in Band 1 among the nation’s leading attorneys for pharmaceuticals and medical products, and clients praise him as “an exceptional FDA attorney” and a “go-to resource.” He is also recognized in The Legal 500 United States Healthcare: Life Sciences Hall of Fame for FDA Law—affirming his status as a trusted strategist for industry-defining matters.

Prior to joining Ropes & Gray, Greg was a partner at an international law firm in Washington, D.C. and served on Capitol Hill as legislative staff in the U.S. House of Representatives, where he helped craft FDA-related legislation, policy, and appropriations. This rare combination of private-sector insight and legislative experience equips him to anticipate regulatory trends, influence policy, and secure favorable outcomes for clients operating at the intersection of science and law.